CIK: 1221599 - Address: 4505 Emperor Boulevard, Suite 200, Durham, NC 27703
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/29/24 16:16
5/24/24
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAselage SteveNCDP166.4003466I
12/1/22 16:01
11/29/22
ACERAcer Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAselage SteveMADP5001.220410555484D
5/12/22 20:35
5/11/22
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsAselage SteveCADS-5621.920-3-2147D
12/13/21 16:02
12/9/21
ACERAcer Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAselage SteveMADP.m212.060101674D
11/18/21 16:08
11/16/21
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsAselage SteveCADS-93529.390-32-18149D
11/9/21 16:05
11/5/21
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsAselage SteveCADM.d16216.230106181D
11/9/21 16:05
11/5/21
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsAselage SteveCADS.d-26226.230-10-5181D
11/3/21 16:05
11/1/21
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsAselage SteveCADS.m-25229.690-9-4181M
10/8/21 16:18
10/7/21
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsAselage SteveCADM.d97416.2306046190D
10/8/21 16:18
10/7/21
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsAselage SteveCADS.d-1,57526.250-60-24190D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact